Advanced breast cancer drug produces positive phase 2 results
A pharmaceutical company has produced positive phase 2 results for its drug to treat advanced breast cancer with an oral version of a chemotherapy treatment. The findings come at a critical time for the drugmaker and could lead to additional investment as it seeks to advance the drug’s development. Genta’s (OTCBB:GNTA) lead drug is tesetaxel, […]